Psagot Value Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Psagot Value Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-110	Closed	-$17K	–	398
2020 Q4	$17K	Hold	110	–	–	﹤0.01%	320
2020 Q3	$13K	Buy	+110	New	+$11.9K	﹤0.01%	368
2018 Q2	–	Sell	-65	Closed	-$7K	–	380
2018 Q1	$7K	Buy	+65	New	+$7.77K	﹤0.01%	320
2017 Q4	–	Sell	-173	Closed	-$24K	–	334
2017 Q3	$24K	Buy	+173	New	+$23.5K	﹤0.01%	280
2016 Q2	–	Sell	-28	Closed	-$4K	–	403
2016 Q1	$4K	Hold	28	–	–	﹤0.01%	357
2015 Q4	$5K	Hold	28	–	–	﹤0.01%	366
2015 Q3	$4K	Hold	28	–	–	﹤0.01%	357
2015 Q2	$5K	Hold	28	–	–	﹤0.01%	362
2015 Q1	$5K	Buy	+28	New	+$5.07K	﹤0.01%	345

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Psagot Value Holdings's ALXN Position: Q1 2021 in Review

Psagot Value Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 110 shares — an estimated $17K sold.

Psagot Value Holdings first reported a position in ALXN in Q1 2015 and held it in 9 quarters. The position peaked at $24K in Q3 2017. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Psagot Value Holdings reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Psagot Value Holdings sold 110 Alexion Pharmaceuticals shares in Q1 2021, an estimated $17K.
Psagot Value Holdings first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 9 quarters.
Psagot Value Holdings's Alexion Pharmaceuticals position peaked at $24K in Q3 2017.
754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Psagot Value Holdings's 13F filing for Q1 2021, filed 18 May 2021.